...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ,Hong Kong exchange

hey,,,,tada,,that ***potential in its assets*** is that something likie the goodwill we see written off in so many takeovers??,,,, :o) ,,hahaha,,,,,just teasing,,,,but yes,,agreed its the market potential whether speculative or known that may get a price above what is generally perceived as a fair price!!,,,,,it maybe the only money maker for us in the end!!,,,and that is a big ol' speculative maybe!

If there was an epigeneric drug already approved by FDA or EDA or other our sledding would be much easier I assume.......!

Share
New Message
Please login to post a reply